Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors

Reproduction

Volumn 149, Issue 2, 2015, Pages 171-178

  Keelan, Jeffrey A ^a   Mas, Emilie ^b   D'Vaz, Nina ^c   Dunstan, Janet A ^c   Li, Shaofu ^a   Barden, Anne E ^b   Mark, Peter J ^d   Waddell, Brendan J ^d   Prescott, Susan L ^c   Mori, Trevor A ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

17 HYDROXYDOCOSAHEXAENOIC ACID; 18 HYDROXYEICOSAPENTAENOIC ACID; AUTACOID; CD59 ANTIGEN; CYTOKINE; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; OMEGA 3 FATTY ACID; PLACEBO; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE 2; RESOLVIN D1; RESOLVIN D2; SPECIALIZED PRORESOLVING LIPID MEDIATOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ERYTHROCYTE; FATTY ACID ANALYSIS; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; IMMUNOMODULATION; INFLAMMATION; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MATERNAL BLOOD; PLACENTA; PREGNANCY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD; CHEMISTRY; DRUG EFFECTS; GENETICS; LIPID METABOLISM;

CYTOKINES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMANS; INFLAMMATION; LIPID METABOLISM; PLACEBOS; PLACENTA; PREGNANCY;

EID: 84921282666     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-14-0549     Document Type: Article

References (44)

1. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N & Serhan CN 2007 Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. Journal of Immunology 178 3912-3917. (doi:10.4049/jimmunol.178.6.3912)
2. Bannenberg G & Serhan CN 2010 Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochimica et Biophysica Acta 1801 1260-1273. (doi:10.1016/j.bbalip.2010.08.002)
3. Barden AE, Dunstan JA, Beilin LJ, Prescott SL &Mori TA 2006 n-3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science 111 289-294. (doi:10.1042/CS20060096)
4. Berghaus TM, Demmelmair H & Koletzko B 1998 Fatty acid composition of lipid classes in maternal and cord plasma at birth. European Journal of Pediatrics 157 763-768. (doi:10.1007/s004310050931)
5. Bowen JM, Chamley L, Keelan JA & Mitchell MD 2002 Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta 23 257-273. (doi:10.1053/plac.2001.0782)
6. Calder PC 2012 Long-chain fatty acids and inflammation. Proceedings of the Nutrition Society 71 284-289. (doi:10.1017/S0029665112000067)
7. Calder PC 2013a Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? British Journal of Clinical Pharmacology 75 645-662. (doi:10.1111/j.1365-2125.2012.04374.x)
8. Calder PC 2013b n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proceedings of the Nutrition Society 72 326-336. (doi:10.1017/S0029665113001031)
9. Campoy C, Escolano-Margarit MV, Anjos T, Szajewska H & Uauy R 2012 Omega 3 fatty acids on child growth, visual acuity and neurodevelopment. British Journal of Nutrition 107 (Suppl 2) S85-S106. (doi:10.1017/S0007114512001493)
10. Colas RA, Shinohara M, Dalli J, Chiang N & Serhan CN 2014 Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. American Journal of Physiology. Cell Physiology 307 C39-C54. (doi:10.1152/ajpcell.00024.2014)
11. Datta K & Kulkarni AP 1994 Oxidative metabolism of aflatoxin B1 by lipoxygenase purified from human term placenta and intrauterine conceptual tissues. Teratology 50 311-317. (doi:10.1002/tera.1420500406)
12. Dunstan JA & Prescott SL 2005 Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants? Current Opinion in Allergy and Clinical Immunology 5 215-221. (doi:10.1097/01.all.0000168784.74582.32)
13. Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG & Prescott SL 2003 Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Immunology 112 1178-1184. (doi:10.1016/j.jaci.2003.09.009)
14. Duttaroy AK 2009 Transport of fatty acids across the human placenta: a review. Progress in Lipid Research 48 52-61. (doi:10.1016/j.plipres.2008.11.001)
15. Haggarty P, Ashton J, Joynson M, Abramovich DR & Page K 1999 Effect of maternal polyunsaturated fatty acid concentration on transport by the human placenta. Biology of the Neonate 75 350-359. (doi:10.1159/ 000014115)
16. Herrera E,Ortega H, Alvino G, Giovannini N, Amusquivar E & Cetin I 2004 Relationship between plasma fatty acid profile and antioxidant vitamins during normal pregnancy. European Journal of Clinical Nutrition 58 1231-1238. (doi:10.1038/sj.ejcn.1601954)
17. Im DS 2012 Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Progress in Lipid Research 51 232-237. (doi:10.1016/j.plipres.2012.02.003)
18. Johnson RD, Polakoski KL, Huang X, Sadovsky Y & Nelson DM 1998 The release of 15-hydroxyeicosatetraenoic acid by human placental trophoblast is increased in preeclampsia. American Journal of Obstetrics and Gynecology 178 54-58. (doi:10.1016/S0002-9378(98)70626-X)
19. Jones ML, Mark PJ, Keelan JA, Barden A, Mas E, Mori TA & Waddell BJ 2013a Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. Journal of Lipid Research 54 2247-2254. (doi:10.1194/jlr.M039842)
20. Jones ML, Mark PJ, Mori TA, Keelan JA & Waddell BJ 2013b Maternal dietary omega-3 fatty acid supplementation reduces placental oxidative stress and increases fetal and placental growth in the rat. Biology of Reproduction 88 37. (doi:10.1095/biolreprod.112.103754)
21. Jones ML, Mark PJ &Waddell BJ 2014 Maternal dietary omega-3 fatty acids and placental function. Reproduction 147 R143-R152. (doi:10.1530/REP-13-0376)
22. Klemens CM, Berman DR & Mozurkewich EL 2011 The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG 118 916-925. (doi:10.1111/j.1471-0528.2010.02846.x)
23. Larque E, Demmelmair H, Gil-Sanchez A, Prieto-Sanchez MT, Blanco JE, Pagan A, Faber FL, Zamora S, Parrilla JJ & Koletzko B 2011 Placental transfer of fatty acids and fetal implications. American Journal of Clinical Nutrition 94 1908S-1913S. (doi:10.3945/ajcn.110.001230)
24. Larque E,Gil-SanchezA,Prieto-SanchezMT&KoletzkoB 2012Omega 3 fatty acids, gestation and pregnancy outcomes. British Journal of Nutrition 107 (Suppl 2) S77-S84. (doi:10.1017/S0007114512001481)
25. Markworth JF, Vella L, Lingard BS, Tull DL, Rupasinghe TW, Sinclair AJ, Maddipati KR&Cameron-SmithD 2013Humaninflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 305 R1281-R1296. (doi:10.1152/ajpregu.00128.2013)
26. Mas E, Croft KD, Zahra P, Barden A & Mori TA 2012 Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clinical Chemistry 58 1476-1484. (doi:10.1373/clinchem.2012.190199)
27. Masoodi M, Mir AA, Petasis NA, Serhan CN & Nicolaou A 2008 Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Communications in Mass Spectrometry 22 75-83. (doi:10.1002/rcm.3331)
28. Mitchell MD & Grzyboski CF 1987 Arachidonic acid metabolism by lipoxygenase pathways in intrauterine tissues of women at term of pregnancy. Prostaglandins, Leukotrienes, and Medicine 28 303-312. (doi:10.1016/0262-1746(87)90119-3)
29. Mognetti B, Moussa M, Croitoru J, Menu E, Dormont D, Roques P & Chaouat G 2000 HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates. Clinical and Experimental Immunology 119 486-492. (doi:10.1046/j.1365-2249.2000.01149.x)
30. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD & Beilin LJ 2000 Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. American Journal of Clinical Nutrition 71 1085-1094.
31. Mozurkewich EL & Klemens C 2012 Omega-3 fatty acids and pregnancy: current implications for practice. Current Opinion in Obstetrics & Gynecology 24 72-77. (doi:10.1097/GCO.0b013e328350fd34)
32. Murthi P, Fitzpatrick E, Borg AJ, Donath S, Brennecke SP & Kalionis B 2008 GAPDH, 18S rRNA and YWHAZ are suitable endogenous reference genes for relative gene expression studies in placental tissues from human idiopathic fetal growth restriction. Placenta 29 798-801. (doi:10.1016/j.placenta.2008.06.007)
33. Nicolaou A, Masoodi M, Mir AA 2009 Lipidomic analysis of prostanoids by liquid chromatography-electrospray tandem mass spectrometry. In Lipidomics: Methods in Molecular Biology, 579 271-286. doi:10.1007/978-1-60761-322-0-14
34. Noguchi K, Ishii S & Shimizu T 2003 Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. Journal of Biological Chemistry 278 25600-25606. (doi:10.1074/jbc.M302648200)
35. Norling LV, Dalli J, Flower RJ, Serhan CN & Perretti M 2012 Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arteriosclerosis, Thrombosis, and Vascular Biology 32 1970-1978. (doi:10.1161/ATVBAHA.112.249508)
36. Palmer DJ, Sullivan T, Gold MS, Prescott SL, Heddle R, Gibson RA & Makrides M 2012 Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ 344 e184. (doi:10.1136/bmj.e184)
37. Patel L, Sullivan MH & Elder MG 1989 Production of epoxygenase metabolite by human reproductive tissues. Prostaglandins 38 615-624. (doi:10.1016/0090-6980(89)90044-0)
38. Rogers LK, Valentine CJ & Keim SA 2013 DHA supplementation: current implications in pregnancy and childhood. Pharmacological Research 70 13-19. (doi:10.1016/j.phrs.2012.12.003)
39. Sakamoto M & Kubota M 2004 Plasma fatty acid profiles in 37 pairs of maternal and umbilical cord blood samples. Environmental Health and Preventive Medicine 9 67-69. (doi:10.1007/BF02897935)
40. Serhan CN & Chiang N 2013 Resolution phase lipid mediators of inflammation: agonists of resolution. Current Opinion in Pharmacology 13 632-640. (doi:10.1016/j.coph.2013.05.012)
41. Wang Y, Zhu D, An Y, Sun J, Cai L & Zheng J 2012 Preeclampsia activates 15-lipoxygenase and its metabolite 15-hydroxyeicosatetraenoic acid enhances constriction in umbilical arteries. Prostaglandins, Leukotrienes, and Essential Fatty Acids 86 79-84. (doi:10.1016/j.plefa.2011.10.006)
42. Weiss GA, Troxler H, Klinke G, Rogler D, Braegger C & HersbergerM2013 High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids in Health and Disease 12 89. (doi:10.1186/1476-511X-12-89)
43. Xu Z, Zhao F, Lin F, Xiang H, Wang N, Ye D & Huang Y 2014 Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator. Fertility and Sterility 102 282-290. (doi:10.1016/j.fertnstert.2014.03.056)
44. Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, Guarda G, Tian Z, Tschopp J & Zhou R 2013 Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38 1154-1163. (doi:10.1016/j.immuni.2013.05.015)